Gilead Sciences (GILD) News Today → How Biden has already won 2024 (From Porter & Company) (Ad) Free gild Stock Alerts $65.96 +1.38 (+2.14%) (As of 05/10/2024 08:55 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineQRG Capital Management Inc. Has $32.56 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - May 12 at 5:50 PMGilead Sciences Q1 Earnings Transcriptmarketbeat.com - May 12 at 7:08 AMDimensional Fund Advisors LP Grows Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - May 11 at 11:47 PMDecoding Gilead Sciences's Options Activity: What's the Big Picture?benzinga.com - May 10 at 7:03 PMGilead Sciences, Inc. (NASDAQ:GILD) Shares Sold by Private Advisor Group LLCmarketbeat.com - May 10 at 8:24 AMArcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Programbusinesswire.com - May 9 at 4:05 PMKite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Programbusinesswire.com - May 9 at 4:05 PMNational Pension Service Acquires 52,214 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - May 9 at 1:05 PMWill Gilead Sciences Stock Recover To Its Pre-Inflation Shock Highs Of Around $75?forbes.com - May 9 at 9:51 AMCharles Schwab Investment Management Inc. Boosts Position in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - May 7 at 9:42 PMGilead Helps Put African Nation on Path To Eliminate Hepatitis Cfinance.yahoo.com - May 7 at 9:57 AMGilead and Kite Oncology to Highlight Broad and Diverse Oncology Portfolio at ASCO 2024businesswire.com - May 7 at 8:30 AMBargain Hunting: 7 Stocks Near 52-Week Lows to Buy Before the Bounce Backinvestorplace.com - May 6 at 12:39 PMGilead Sciences, Inc. (NASDAQ:GILD) Shares Acquired by Natixis Advisors L.P.marketbeat.com - May 6 at 7:35 AMGilead Sciences, Inc. (NASDAQ:GILD) Stock Holdings Lifted by Sheets Smith Wealth Managementmarketbeat.com - May 5 at 10:58 PMGilead Sciences (NASDAQ:GILD) Sets New 52-Week Low at $64.42americanbankingnews.com - May 5 at 3:50 AMTodd Asset Management LLC Has $974,000 Stake in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - May 4 at 2:30 PMGilead Sciences, Inc. (NASDAQ:GILD) Receives Average Recommendation of "Hold" from Brokeragesamericanbankingnews.com - May 4 at 3:48 AMAmalgamated Bank Sells 19,072 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - May 3 at 11:38 PMForbes Has Listed Gilead as One of America’s Best Employers for Diversityfinance.yahoo.com - May 3 at 11:36 PMGilead Sciences (NASDAQ:GILD) Sets New 1-Year Low at $64.42marketbeat.com - May 3 at 8:53 PMGilead Sciences (NASDAQ:GILD) PT Lowered to $85.00americanbankingnews.com - May 3 at 6:04 AMMcAdam LLC Has $1.63 Million Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - May 3 at 12:08 AMShhh! 3 Secret Biotech Stocks Flying Below Wall Street's Radarinvestorplace.com - May 1 at 2:38 PMGilead Sciences (NASDAQ:GILD) Price Target Lowered to $85.00 at Maxim Groupmarketbeat.com - May 1 at 8:32 AMNorden Group LLC Raises Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 30 at 2:27 PMAnalysts Conflicted on These Healthcare Names: Annovis Bio (ANVS), Gilead Sciences (GILD) and Omega Therapeutics (OMGA)markets.businessinsider.com - April 30 at 10:53 AMGilead Sciences: Hold Rating Justified Amid Stable Outlook and Upcoming Oncology Catalystsmarkets.businessinsider.com - April 30 at 10:53 AMRaymond James & Associates Trims Stake in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 29 at 11:30 PMGilead Sciences: First-Quarter Results Beat Estimatesfool.com - April 29 at 6:57 PMGilead Sciences: Hold Rating with Cautious Outlook Amidst Market Challenges and Growth Uncertaintiesmarkets.businessinsider.com - April 29 at 1:48 PMTraders Purchase Large Volume of Gilead Sciences Call Options (NASDAQ:GILD)marketbeat.com - April 29 at 1:01 PMBarclays Cuts Gilead Sciences (NASDAQ:GILD) Price Target to $76.00marketbeat.com - April 29 at 11:36 AMGilead Sciences, Inc. (GILD) Q1 2024 Earnings Call Transcriptseekingalpha.com - April 29 at 12:53 AMPFG Investments LLC Purchases 27,709 Shares of Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 29 at 12:15 AMSector Gamma AS Has $30.98 Million Stock Holdings in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 27 at 4:38 PMGilead Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lagsfinance.yahoo.com - April 27 at 1:37 PMGilead Sciences, Inc. Declares Quarterly Dividend of $0.77 (NASDAQ:GILD)marketbeat.com - April 27 at 11:15 AMTruist Financial Reaffirms Their Hold Rating on Gilead Sciences (GILD)markets.businessinsider.com - April 26 at 10:36 PMBank Julius Baer & Co. Ltd Zurich Has $34.83 Million Stake in Gilead Sciences, Inc. (NASDAQ:GILD)marketbeat.com - April 26 at 8:17 PMMorgan Stanley Lowers Gilead Sciences (NASDAQ:GILD) Price Target to $78.00marketbeat.com - April 26 at 2:28 PMGilead Sciences Says FDA OK's Updated Label Of Biktarvy To Treat Pregnant People With HIV-1markets.businessinsider.com - April 26 at 12:34 PMGilead Gives Up Big Gains As Covid Drug Drives Its Beat — Againfinance.yahoo.com - April 26 at 12:34 PMGilead Sciences (NASDAQ:GILD) Receives "Hold" Rating from Needham & Company LLCmarketbeat.com - April 26 at 8:43 AMGilead: Q1 Earnings Snapshotwashingtonpost.com - April 26 at 7:34 AMGilead Sciences Inc (GILD) Q1 2024 Earnings Call Transcript Highlights: Key Financials and ...finance.yahoo.com - April 26 at 7:34 AMDow Inc. Q1 Earnings Summarymarkets.businessinsider.com - April 25 at 9:33 PMGilead’s quarterly loss is narrower than expectedmsn.com - April 25 at 9:33 PMGilead Sciences, Inc. 2024 Q1 - Results - Earnings Call Presentationseekingalpha.com - April 25 at 8:14 PMGILD Stock Earnings: Gilead Sciences Beats EPS, Beats Revenue for Q1 2024investorplace.com - April 25 at 8:11 PM Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Forget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THIS (Ad)You might have seen that Bitcoin was one of the best performing assets of 2023. It gained 164%. But a crypto millionaire who has been tracking the space for more than a decade has ABANDONED Bitcoin. He found something better. Click here to find out that this 8,788% cryptocurrency is. GILD Media Mentions By Week GILD Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GILD News Sentiment▼0.710.58▲Average Medical News Sentiment GILD News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GILD Articles This Week▼1616▲GILD Articles Average Week Get Gilead Sciences News Delivered to You Automatically Sign up to receive the latest news and ratings for GILD and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: SGEN News Today BIIB News Today NBIX News Today TECH News Today QGEN News Today RGEN News Today CRSP News Today DNLI News Today AMGN News Today MRNA News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GILD) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorDid You Get Your Free Bitcoin Yet?Crypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsCharles Payne Demystifies OptionsUnstoppable ProsperityTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gilead Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
